[1] 尚丽霞,梁振湖,张红蕾,等.醒脑静注射液对急性缺血性脑卒中患者血清hs-CRP、TNF-α和IL-6的影响及疗效观察[J].中国民康医学,2015,27(5):84.
[2] 伍苏方,许宏伟,杨平生.依达拉奉联合奥扎格雷治疗缺血性脑卒中40例[J].中国药业,2014,23(19):106.
[3] 全国第四届血管病学术会议.脑卒中病人神经功能缺损程度评分标准及临床疗效评定标准[J].中华神经科杂志,1996,29(6):381.
[4] 周业旺.依达拉奉联合奥扎格雷钠治疗急性脑梗死120例临床观察[J].实用临床医药杂志,2011,15(3):68.
[5] 卢君慧.氯吡格雷联合小剂量阿司匹林治疗急性缺血性脑卒中患者的疗效及安全性评估[J].中国民康医学,2014,26(5):18.
[6] 张爱香,韦君丽.缺血性脑卒中危险因素研究进展[J].吉林医学,2010,31(17):2678.
[7] 王桂斌,刘运海.依达拉奉对缺血性脑卒中的治疗作用及机制研究进展[J].国际神经病学神经外科学杂志,2013,40(2):168.
[8] JIAO L,ZHANG J,LI Z,et al.Edaravone alleviates delayed neuronal death and long-dated cognitive dysfunction of hippocampus after transient focal ischemia in Wistar rat brains[J].Neuroscience,2011,182(1):177.
[9] ZHANG P,LI W,LI L,et al.Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury[J].Neuroscience,2012,201(2):297.
[10] SHARMA P,SINHA M,SHUKLA R,et al.A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke[J].Ann Indian Acad Neurol,2011,14(2):103.
[11] LIU N,SHANG J,TIAN F,et al.In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice[J].Brain Res,2011,1397(1):66.
[12] YANG B,SHI J,CHEN X,et al.Efficacy and safety of therapies for acute ischemic stroke in China:a network meta-analysis of 13 289 patients from 145 randomied controlled trials[J].PloS One,2014,9(2):e88440.
[13] ISHIBASHI A,YOSHITAKE Y,ADACHI H.Investigation of effect of edaravone on ischemic stroke[J].Kurume Med J,2013,60(2):53.
[14] SHINOHARA Y,INOUE S.Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolic cerebral infarction[J].J Stroke Cerebrovasc Dis,2013,22(5):668.
[15] SHINOHARA Y,SAITO I,KOBAYASHI S,et al.Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial)[J].Cerebrovasc Dis,2009,27(5):485.
[16] 郭秉青.依达拉奉联合奥扎格雷钠治疗进展性缺血性脑卒中疗效观察[J].中国现代药物应用,2014,8(20):98.